When fluoxetine fails, what next? A national survey controlling for age

References

• Altamura, A.C., Montgomery, S.A. & Wernicke, J.F. (1988). The evidence for 20 mg a day of fluoxetine as the optimal dose in the treatment of depression. British Journal of Psychiatry, 153 (suppl 3), 109–112.
   Web of Science ®Google Scholar
• Austin, M.P.V., Souza, F.G.M. & Goodwin, G.W. (1991). Lithium augmentation in tricyclic resistant patients: a qualitative analaysis. British Journal of Psychiatry, 159, 510–514.
   PubMed Web of Science ®Google Scholar
• Benbow, S.M. (1989). The role of electroconvulsive therapy in the treatment of depressive illness in old age. British Journal of Psychiatry, 155, 147–152.
   PubMed Web of Science ®Google Scholar
• Bergstrom, R.F., Lemberger, L., Farid, N.A. & Wolen, R.L. (1988). Clinical pharmacology and pharma-cokinetics of fluoxetine : a review. British Journal of Psychiatry, 153, 47–50.
   Web of Science ®Google Scholar
• British National Formulary (1996). No. 31, London, Royal Pharmaceutical Society.
   Google Scholar
• Buchan, H., Johnstone, E., McPherson, K.,Palmer, R.L., Crow, T.J. & Brandon, S. (1992). Who ben-efits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. British Journal of Psychiatry, 160, 355–359.
   Google Scholar
• Cain, J.W. (1992). Poor response to fluoxetine: Under-lying depression, serotonergic over stimulation, or a therapeutic window? Journal of Clinical Psy-chiatry, 53, 272–277.
   Google Scholar
• Cole, A.J., Brittlebank, A.D. & Scott, J. (1994). The role of cognitive therapy in refractory depression. In: Nolen, W.A., Zohar, J., Roose, S.P. & Amster-dam, J.D. (Eds) Refractory Depression: Current strategies and future direc tions, pp. 117–120. Chich-ester, John Wiley & Sons.
   Google Scholar
• Cooper, G.L. (1988). The safety of fluoxetine: an update. British Journal of_Psychiatry, 153, 77–86.
   Web of Science ®Google Scholar
• Devanand, D.P., Sackeim, H.A. & Prudic, J. (1991). Electroconvulsive therapy in the treatment - resist-ant patient. Psychiatric Clinics of North America, 14, 905–923.
   PubMed Web of Science ®Google Scholar
• De Montigny, C. (1994) Lithium addition in refractory depression. In: Nolen, W.A., Zohar, J., Roo se, S.P. & Amsterdam, J.D. (Eds) Refractory Depression: Current strategies and future directions pp. 47–57. Chichester, John Wiley & Sons.
   Google Scholar
• Dinan, T.G. & Barry, S. (1989). A Comparison of electroconvulsive therapy with a lithium and tricyclic combination among depressed tricyclic non-responders. Acta Psychiatrica Scandanavica, 8, 97–100.
   Google Scholar
• Fava, M., Rosenbaum, J.F., Cohen, L., Reiter, S., McCarthy, M., Steingard, R. & Clancy, K. (1992). High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine. Journal of Affe ctive Disorders, 25, 229–234.
   PubMed Web of Science ®Google Scholar
• Fava, M., Rosenbaum, J.F., McGrath, P.J., Stewart, J.W., Amsterdam, J.D. & Quitkin, F. M. (1994). Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: A double-blind controlled study. American Journal of Psy-chiatry, 151, 1372–1374.
   PubMed Web of Science ®Google Scholar
• Feighner, J.P., Boyer, W.F., Meredith, C.H. & Hendrickson, G. (1988). An overview of fluoxetine in geriatric depression. British Journal of Psychia-try, 153, 105–108.
   PubMed Web of Science ®Google Scholar
• Hopwood, SE., Bogle, S. & Wildgust, H.J. (1993) The combination of lithium and fluoxetine in clinical practice. International Clinical Psychopharma-cology, 8, 325–327.
   Google Scholar
• Katona, C.L.E., Abou-Saleh, M.T., Harrison, D.A. Nairac, B.A., Edwards, D.R.L., Lock, T., Burns, R.A. & Robertson, M.M. (1995). Placebo-control-led trial of lithium augmentation of fluoxetine and lofepramine. British Journal of Psychiatry, 166, 80–86.
   PubMed Web of Science ®Google Scholar
• Malcolm, K. & Peet, M. (1989). The use of electrocon-vulsive therapy in elderly depressive patients. In : Ghose, K. (Ed) 'Antidepressants for elderly peo-ple'. London, Chapman & Hall.
   Google Scholar
• Malizia, A.L. & Bridges, P.K. (1992). The manage-ment oftreatment-resistant affective disorder: Clini-cal perspectives. Journal ofPsychopharmacology, 6, 145–155.
   PubMed Web of Science ®Google Scholar
• National Institute of Health (1993). Diagnosis and treatment of depression in late life: The NIH con-sensus development conference statement. Psy-chopharmacology Bulletin, 29, 87–100.
   PubMedGoogle Scholar
• Nelson, J.L. (1993). Combined treatment strategies in Psychiatry. Journal of Clinical Psychiatry, 54,42–49.
   PubMed Web of Science ®Google Scholar
• Nierenberg, A.A. (1991). Treatment choice after one antidepressant fails: A survey of north eastern psychiatrists. Journal of Clinical Psychiatry, 52, 383–385.
   PubMed Web of Science ®Google Scholar
• Nolen, W.A., Van de Putte, J.,J., Dijken, W.A., Kamp, J. S., Blansjaar, B.A., Kramer, H.J. & Haffmans, J. (1988). Treatment strategy in depression. I: Non-tricyclic and selective serotoninreuptake inhibitors in resistant depression: A double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine. Acta Psychiatrica Scandanavica, 78, 668–675.
   Google Scholar
• Nolen, W.A., Zohar, J. & Roose, S.P. (Eds) (1994). Refractory Depression: Current strategies and fu-ture directions. Chichester, John Wiley & Sons.
   Google Scholar
• Ontiveros, A., Fontaine, R. & Elie, R. (1991). Refrac-tory depression: the addition of lithiumto fluoxetine or desipramine. Acta Psychiatrica Scandanavica, 83, 188–192.
   PubMed Web of Science ®Google Scholar
• Sackeim, HA., Prudic, J. & Devanand, D.P., (1990). The impact of medication resistance and continua-tion pharmacotherapy or relapse following response to electroconvulsive therapy in major depression. Journal of Clinical Psychopharmacology,10, 96–104.
   Google Scholar
• Schweizer, E., Rickel, S.K., Amsterdam, J.D., Fox, I., Puzzvoli, G. & Weise, C. (1990). What constitutes an adequate antidepressant trial for fluoxetine? Journal of Clinical Psychiatry, 51, 8–11.
   Google Scholar
• Scott, J. (1992). Chronic depression: Can cognitive therapy succeed when other treatments fail? Be-havioural Psychotherapy, 20, 25–36.
   Google Scholar
• Stravynski, A. & Greenberg, D. (1992). The psycho-logical management of depression. Acta Psychiatrica Scandanavica, 86, 407–414.
   Google Scholar
• Weilburg, J.B., Rosenbaum, J.F., Melzer-Brody, S. & Shustari, J. (1991). Tricyclic augmentation of fluoxetine. Annals of Clinical Psychiatry, 3, 209–213.
   Google Scholar
• Wernicke, J.F., Dunlop, SR., Dornseif, B.E. & Zerbe, R.L. (1987). Fixed dose fluoxetine therapy for depression. Psychopharmacology Bulletin, 23, 164–168.
   Google Scholar
• Wilkinson, A.M., Anderson, D.N. & Peters, S. (1993). Age and the effects of ECT. International Journal of Geriatric Psychiatry, 8, 401–406.
   Web of Science ®Google Scholar